306-OR: Mazdutide vs. Placebo as Monotherapy in Patients with Type 2 Diabetes (DREAMS-1)
Dalong Zhu, Lei Qian, Shuangling Xiu, Hongwei� Jiang(First Affiliated Hospital of Henan University of Science and Technology), Haoyu Li(Qingdao University), Li Li, Zhifeng Cheng(Harbin Medical University), Lili Zhang(Northeast Forestry University), Cai H, Chengwei Song(Henan University of Science and Technology), Huan Deng(Nanchang University), Jiajun Zhao(Shandong Provincial Hospital)
Cited by 2
Related Papers
Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease
|Cell Metabolism|2024|208
Eicosapentaenoic and docosahexaenoic acids attenuate hyperglycemia through the microbiome-gut-organs axis in db/db mice
|Microbiome|2021|167
Epidemiology of Type 2 Diabetic Foot Problems and Predictive Factors for Amputation in China
|The International Journal of Lower Extremity Wounds|2015|153
Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol
|Cell Research|2018|123